Al Hammadi Holding Company — Cyborg Score 7/10

Strong
Healthcare Services & Hospital Operations

Strategic Profile

With 35+ years of operational excellence, Al Hammadi maintains a diversified healthcare ecosystem spanning hospital operations, pharmaceutical services, specialty care medications through Sudair Pharma (35% stake), and biotech innovation. The company leverages Saudi Vision 2030 growth initiatives while establishing itself as a vertically integrated healthcare provider with significant competitive advantages in the Saudi healthcare landscape.

Cyborg Score Rationale

Al Hammadi demonstrates solid fundamentals with strong revenue growth (18% YoY in 2022 to 1.12B SAR), healthy profitability (22.9% net margin), and strategic diversification across hospital operations, pharmaceuticals, and biotech. Trading at 33.1% discount to fair value suggests undervaluation, though limited recent data limits visibility.

Top Insights

  • Vertically integrated model spanning acute care hospitals, pharmaceutical distribution, specialty pharma (Sudair 35% stake), and biotech innovation positions company as comprehensive healthcare provider
  • Strong financial performance in 2022 with 18% revenue growth to SAR 1.12B and 26% operating profit growth demonstrates operational leverage and pricing power
  • Currently trading 33% below fair value estimate per analyst assessments, suggesting potential valuation opportunity
  • 35-year operational heritage and Vision 2030 alignment provide competitive moat in growing Saudi healthcare market

Named Competitors

  • Hospital Operations and Healthcare Services — Large-scale hospital network operator in Saudi Arabia
  • Hospital Operations and Healthcare Services — Multi-hospital healthcare provider in Saudi Arabia
  • Specialty Pharmaceuticals — Specialty care medications focusing on cancer and chronic disease treatments

Recent Developments

  • Q4 2025 earnings release scheduled for March 23, 2026
  • Company maintains analyst coverage with 16 analysts following the stock as of September 2025

Open the full interactive Al Hammadi Holding Company report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →